Amneal Pharmaceuticals: Flattish 2026 Revenue Growth Aside, Stock Still Looks A Buy
…
13,115$
2,22%
Echtzeit-Aktienkurs Amneal Pharmaceuticals
Bid:
Ask:
Nachrichten zur Amneal Pharmaceuticals Aktie
Truist raises Amneal Pharmaceuticals stock price target on margin focus
Truist raises Amneal Pharmaceuticals stock price target on margin focus…
Is Amneal Pharmaceuticals (AMRX) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026
BRIDGEWATER, N.J., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today…
Amneal Pharmaceuticals, Inc. (AMRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
…
FDA Approves First Generic Omnipaque: Might Change The Case For Investing In Amneal Pharmaceuticals (AMRX)
Amneal Pharmaceuticals announced that the U.S. FDA has approved its iohexol injection (300 mg Iodine/mL), the first generic version of…
Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy?
Amneal (AMRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
Amneal Announces Proposed Refinancing of Existing Credit Agreement, including Private Offering of Senior Secured Notes Due 2032
BRIDGEWATER, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal”) (Nasdaq: AMRX) announced that its subsidiary,…
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2025 Earnings Call Transcript
…
Amneal Pharmaceuticals (AMRX) Q1 Earnings Beat Estimates
Amneal (AMRX) delivered earnings and revenue surprises of 40% and 2.71%, respectively, for the quarter ended March 2025. Do the…
Amneal Pharmaceuticals (AMRX) Reports Next Week: Wall Street Expects Earnings Growth
Amneal (AMRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
Amneal Pharmaceuticals, Inc. (AMRX) Q3 2024 Earnings Call Transcript
…
Amneal Pharmaceuticals, Inc. (AMRX) Q2 2024 Earnings Call Transcript
…
Amneal Pharmaceuticals (AMRX) Beats Q2 Earnings and Revenue Estimates
Amneal (AMRX) delivered earnings and revenue surprises of 14.29% and 6.75%, respectively, for the quarter ended June 2024. Do the…
Amneal Pharmaceuticals: Maintaining Momentum Is Key To Success
…
Global Muscle Relaxant Drugs Market Size To Worth USD 5.91 Billion By 2033 | CAGR Of 4.24%
The Global Muscle Relaxant Drugs Market Size was Valued at USD 3.90 Billion in 2023 and the Worldwide Muscle Relaxant…
Global Parkinson’s Disease Treatment Market Size To Worth USD 9.14 Billion By 2033 | CAGR Of 6.41%
The Global Parkinsons Disease Treatment Market Size was Valued at USD 4.91 Billion in 2023 and the Worldwide Parkinsons Disease…
Canadian Pharma Stocks: 5 Biggest Companies in 2024
The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription…
Amneal Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
…
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2024 Earnings Call Transcript
…
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Amneal Pharmaceuticals said on Friday it had reached a deal valued at more than $270 million to resolve claims it…
Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates
Amneal (AMRX) delivered earnings and revenue surprises of 55.56% and 5.80%, respectively, for the quarter ended March 2024. Do the…
Global Testosterone Replacement Therapy Market Size To Worth USD 2.93 Billion By 2033 | CAGR Of 4.0%
The Global Testosterone Replacement Therapy Market Size was Valued at USD 1.98 Billion in 2023 and the Worldwide Testosterone Replacement…
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
Bausch (BHC) initiates litigation against Amneal Pharmaceuticals and its subsidiaries over a generic version of its lead drug Xifaxan.…
Global Pregabalin Market Size To Worth USD 2.18 Billion By 2033 | CAGR of 2.82%
The Global Pregabalin Market Size was Valued at USD 1.65 Billion in 2023 and the Worldwide Pregabalin Market Size is…
Earnings call: Amneal Pharmaceuticals sees growth and diversification in 2023 By Investing.com
Earnings call: Amneal Pharmaceuticals sees growth and diversification in 2023…
Amneal Pharmaceuticals, Inc. (AMRX) Q4 2023 Earnings Call Transcript
…
Amneal Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
…
Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings Estimates
Amneal (AMRX) delivered earnings and revenue surprises of 100% and 2.17%, respectively, for the quarter ended December 2023. Do the…